Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.75 USD | +0.81% | -1.57% | +108.33% |
May. 14 | Pyxis Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 14 | Earnings Flash (PYXS) PYXIS ONCOLOGY Posts Q1 Revenue $16.1M | MT |
Financials (USD)
Sales 2024 * | 12.89M | Sales 2025 * | - | Capitalization | 220M |
---|---|---|---|---|---|
Net income 2024 * | -59M | Net income 2025 * | -87M | EV / Sales 2024 * | 17.1 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.95
x | P/E ratio 2025 * |
-2.61
x | Employees | 51 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.16% |
1 day | +0.81% | ||
1 week | -1.57% | ||
Current month | +0.27% | ||
1 month | -15.73% | ||
3 months | -41.04% | ||
6 months | +135.85% | ||
Current year | +108.33% |
Managers | Title | Age | Since |
---|---|---|---|
Lara Sullivan
CEO | Chief Executive Officer | 51 | 19-12-10 |
Pamela Connealy
DFI | Director of Finance/CFO | 62 | 21-06-30 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Flavin
FOU | Founder | 55 | 18-06-10 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 21-08-31 |
Darren Cline
BRD | Director/Board Member | 59 | 21-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 3.74 | +0.54% | 246,197 |
24-05-30 | 3.72 | -2.11% | 264,016 |
24-05-29 | 3.8 | +1.60% | 204,254 |
24-05-28 | 3.74 | -1.84% | 626,499 |
24-05-24 | 3.81 | -0.26% | 192,650 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+108.33% | 221M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- PYXS Stock